Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation
1997

The Role of p16 in Cervical Cancer Development

Sample size: 14 publication Evidence: moderate

Author Information

Author(s): Y Nakao, X Yang, M Yokoyama, A FerenCzy, S-C Tang, MM Pater, A Pater

Primary Institution: Memorial University of Newfoundland

Hypothesis

The disruption of the p16/cdk-cyclin/Rb cascade is essential for malignant cervical transformation.

Conclusion

The inactivation of the p16/cdk-cyclin/Rb cascade does not occur during malignant transformation but during immortalization by HPV.

Supporting Evidence

  • p16 RNA levels increased dramatically after immortalization by HPV 16 or 18.
  • No further changes in p16 levels were observed after malignant transformation.
  • Point mutations or homozygous deletions of p16 were not found in the in vitro systems or clinical specimens.

Takeaway

This study found that a gene called p16 is important for stopping cells from growing too fast, and it gets activated when cells are changed by a virus, but it doesn't change when those cells become cancerous.

Methodology

The study used in vitro model systems of cervical cancer to examine p16 expression at different stages of oncogenic progression.

Limitations

The number of clinical samples was limited, and some samples may have been contaminated with normal tissue.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication